VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, December 31, 2025
Stock Comparison
Enbridge Inc. vs Novo Nordisk A/S
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Enbridge Inc.
ENB · Toronto Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Enbridge Inc.'s moat claims, evidence, and risks.
View ENB analysisNovo Nordisk A/S
NOVOB · Nasdaq Copenhagen
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Novo Nordisk A/S's moat claims, evidence, and risks.
View NOVOB analysisComparison highlights
- Moat score gap: Enbridge Inc. leads (92 / 100 vs 85 / 100 for Novo Nordisk A/S).
- Segment focus: Enbridge Inc. has 4 segments (72.8% in Liquids Pipelines); Novo Nordisk A/S has 3 segments (71.1% in Diabetes care).
- Moat breadth: Enbridge Inc. has 6 moat types across 3 domains; Novo Nordisk A/S has 5 across 3.
Primary market context
Enbridge Inc.
Liquids Pipelines
Crude oil & liquids pipeline transportation plus terminals/storage
North America (Canada & U.S.)
Producers, refiners, marketers (shippers)
Midstream pipeline operator
72.8%
Novo Nordisk A/S
Diabetes care
Diabetes pharmaceuticals (GLP-1 for type 2 diabetes, insulin, and related therapies)
Global
Payers/providers and patients (via wholesalers/pharmacies/hospitals)
Originator pharma (R&D, regulatory, manufacturing, commercialization)
71.1%
Side-by-side metrics
Moat coverage
Shared moat types
Enbridge Inc. strengths
Novo Nordisk A/S strengths
Segment mix
Enbridge Inc. segments
Full profile >Liquids Pipelines
Oligopoly
Gas Transmission and Midstream
Oligopoly
Gas Distribution and Storage
Monopoly
Renewable Power Generation
Competitive
Novo Nordisk A/S segments
Full profile >Diabetes care
Oligopoly
Obesity care
Duopoly
Rare disease
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.